Kubient (NasdaqCM: KBNT, KBNTW) ("Kubient" or the "Company"), a cloud-based software platform for digital advertising, announced today that the United States Patent and Trademark Office
Companies Reporting Before The Bell
• Opiant Pharma (NASDAQ:OPNT) is estimated to report quarterly loss at $1.49 per share on revenue of $3.68 million.
Kubient (NASDAQ:KBNT) is set to give its latest quarterly earnings report on Monday, 2022-11-14. Here's what investors need to know before the announcement.
Analysts estimate that Kubient will report an earnings per share (EPS) of $-0.26.